NL9001714A - Farmaceutisch prepraat voor orale toediening bevattende nac. - Google Patents

Farmaceutisch prepraat voor orale toediening bevattende nac. Download PDF

Info

Publication number
NL9001714A
NL9001714A NL9001714A NL9001714A NL9001714A NL 9001714 A NL9001714 A NL 9001714A NL 9001714 A NL9001714 A NL 9001714A NL 9001714 A NL9001714 A NL 9001714A NL 9001714 A NL9001714 A NL 9001714A
Authority
NL
Netherlands
Prior art keywords
nac
tham
group
molar ratio
cysteine
Prior art date
Application number
NL9001714A
Other languages
English (en)
Dutch (nl)
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of NL9001714A publication Critical patent/NL9001714A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL9001714A 1989-07-27 1990-07-27 Farmaceutisch prepraat voor orale toediening bevattende nac. NL9001714A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT8921339A IT1231012B (it) 1989-07-27 1989-07-27 Composizione farmaceutica per uso orale contenente nac.
IT2133989 1989-07-27

Publications (1)

Publication Number Publication Date
NL9001714A true NL9001714A (nl) 1991-02-18

Family

ID=11180335

Family Applications (1)

Application Number Title Priority Date Filing Date
NL9001714A NL9001714A (nl) 1989-07-27 1990-07-27 Farmaceutisch prepraat voor orale toediening bevattende nac.

Country Status (20)

Country Link
US (1) US5080906A (ja)
JP (1) JPH0399012A (ja)
KR (1) KR910002438A (ja)
AU (1) AU625925B2 (ja)
BE (1) BE1003188A4 (ja)
CA (1) CA2021808A1 (ja)
CH (1) CH680190A5 (ja)
DE (1) DE4023774A1 (ja)
DK (1) DK177890A (ja)
FI (1) FI903759A0 (ja)
FR (1) FR2650503B1 (ja)
GB (1) GB2234171B (ja)
GR (1) GR900100569A (ja)
IE (1) IE902627A1 (ja)
IL (1) IL95158A0 (ja)
IT (1) IT1231012B (ja)
NL (1) NL9001714A (ja)
NZ (1) NZ234647A (ja)
SE (1) SE9002500L (ja)
ZA (1) ZA905861B (ja)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580577A (en) * 1990-01-11 1996-12-03 Herzenberg; Leonard A. Method of treating the symptoms of human rhinovirus infection
US5286480A (en) * 1992-06-29 1994-02-15 The Procter & Gamble Company Use of N-acetylated amino acid complexes in oral care compositions
IT1256616B (it) * 1992-12-02 1995-12-12 Zambon Spa Sciroppo contenente n-acetil-cisteina
GB9226729D0 (en) * 1992-12-22 1993-02-17 Wellcome Found Therapeutic combination
US5637616A (en) * 1993-06-18 1997-06-10 Arcturus Pharmaceutical Corporation Method for treating diseases mediated by proteases
BE1007926A3 (fr) * 1994-01-31 1995-11-21 Zambon Int Pharma Composition pharmaceutique contenant de la n-acetyl-cysteine.
US6896899B2 (en) * 1996-12-31 2005-05-24 Antioxidant Pharmaceuticals Corp. Pharmaceutical preparations of glutathione and methods of administration thereof
EP0957901B1 (en) 1996-12-31 2009-11-18 Antioxidant Pharmaceuticals Corporation Pharmaceutical preparations of glutathione and methods of administration thereof
FR2803720B1 (fr) 2000-01-18 2004-10-22 Roquette Freres Lozenges a base de dextrose et leur procede de fabrication
US6114387A (en) * 2000-02-16 2000-09-05 Cutler; Paul Pharmaceutical composition for oral administration of chelating agents
US6632459B2 (en) * 2000-12-11 2003-10-14 Nutricia N.V. Chlorogenic acid and an analog thereof for immune system stimulation
US20030162732A1 (en) * 2001-07-05 2003-08-28 Astion Development A/S Combination of aminosugars and cysteine or cysteine derivatives
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
ITMI20021881A1 (it) * 2002-09-04 2004-03-05 Zambon Spa Composizioni farmaceutiche per il trattamento di infezioni da patogeni dell'apparato urinario.
US20050008699A1 (en) * 2003-07-11 2005-01-13 Fred Wehling Effervescent glucosamine composition
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
KR20050104152A (ko) * 2004-04-28 2005-11-02 최승호 경구용 약물의 흡수를 증진하는 약제학적 조성물
US20090197956A1 (en) * 2008-02-04 2009-08-06 Arbor Pharmaceuticals, Inc. Treatment of acute otitis media with xylitol and n-acetylcysteine
TR200900882A2 (tr) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tadı ve kokusu maskelenmiş, bıyoyararlanımı yüksek farmasotık bileşimler.
WO2018108960A1 (en) * 2016-12-15 2018-06-21 Zambon S.P.A. N-acetylcysteine for use as antibacterial agent
US20210260012A1 (en) * 2018-07-27 2021-08-26 I.C.F. Srl Compositions for the prevention and treatment of cutaneous affections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081534A (en) * 1973-09-11 1978-03-28 Burroughs Wellcome Co. Amino purine nucleosides as autoimmune suppressant agents
US4877612A (en) * 1985-05-20 1989-10-31 Frank M. Berger Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process
CH667590A5 (it) * 1986-07-24 1988-10-31 Inpharzam Int Sa Composizione farmaceutica effervescente idrosolubile contenente n-acetil-cisteina. .
US4894225A (en) * 1987-03-02 1990-01-16 Cetus Corporation Combination therapy using antitumor immunotoxins with tumor necrosis factor
JPS63290824A (ja) * 1987-05-22 1988-11-28 Sumitomo Chem Co Ltd ウイルス感染症治療剤
IT1217445B (it) * 1988-04-29 1990-03-22 Altergon Sa Composizione farmaceutiche orosolubili contenti acetilcisteina

Also Published As

Publication number Publication date
IL95158A0 (en) 1991-06-10
NZ234647A (en) 1992-02-25
AU625925B2 (en) 1992-07-16
GB2234171B (en) 1993-11-10
JPH0399012A (ja) 1991-04-24
IT1231012B (it) 1991-11-08
DE4023774A1 (de) 1991-01-31
FR2650503A1 (fr) 1991-02-08
CA2021808A1 (en) 1991-01-28
SE9002500D0 (sv) 1990-07-26
SE9002500L (sv) 1991-01-28
IT8921339A0 (it) 1989-07-27
AU5993590A (en) 1991-01-31
DK177890A (da) 1991-01-28
GR900100569A (el) 1991-12-10
FI903759A0 (fi) 1990-07-27
US5080906A (en) 1992-01-14
KR910002438A (ko) 1991-02-25
IE902627A1 (en) 1991-02-27
GB9016256D0 (en) 1990-09-12
DK177890D0 (da) 1990-07-26
GB2234171A (en) 1991-01-30
FR2650503B1 (fr) 1992-05-29
ZA905861B (en) 1991-07-31
BE1003188A4 (fr) 1992-01-07
CH680190A5 (ja) 1992-07-15

Similar Documents

Publication Publication Date Title
NL9001714A (nl) Farmaceutisch prepraat voor orale toediening bevattende nac.
TWI389688B (zh) Vx-950之形態與調配物及其製備方法與用途
US20070286911A1 (en) Huperzia serrate (thunb.) trev. composition comprising compounded huperzine a and huperzine b and methods for preparing it
EA000534B1 (ru) Карбапенемовый антибиотик, композиция и способ получения
KR20040063913A (ko) 2-(4-이소부틸페닐)프로피온산의 약학 조성물
JPH0248526A (ja) インドメタシン注射剤およびその製造方法
CA1297407C (en) Pharmaceutical which can be administered nasally, a process for it preparation, and its use
EP0633787A1 (en) Pharmaceutical composition
JP2004517939A (ja) 初期アルツハイマー病の予防および治療に用いられるクリプトタンシノン
SEKINE et al. Improvement of bioavailability of poorly absorbed drugs. II. Effect of medium chain glyceride base on the intestinal absorption of cefmetazole sodium in rats and dogs
WO2001012204A2 (en) Xanthine oxidase inhibitor containing compositions for the treatment of acetaminophen intoxication
JP2003504395A5 (ja)
LU85854A1 (fr) Procede de traitement medical de maladies virales utilisant le 1-beta-d-ribofurannosyl-1,2,4-triazole-3-carboxamide
Newmark et al. Coumermycin a1—biopharmaceutical studies I
EP0486921A1 (en) N-acetyl-L-cysteine magnesium salt and pharmaceutical compositions containing it
US20080107746A1 (en) Anti-inflamatory inhalation pharmaceutical composition
RU2761828C2 (ru) Фармацевтическая композиция, содержащая бензокаин с усиленной стабильностью
KR0129798B1 (ko) 간염의 예방 및 치료용 의약 조성물
Yamanaka et al. Clinical pharmacokinetics of oseltamivir and its active metabolite oseltamivir carboxylate after oral administration in horses
FR2535205A1 (fr) Solution pour injection a base de substances antirhumatismales et d'une cobalamine et procede pour sa preparation
WO2022076683A1 (en) Methods of treating coronaviral infection with obeticholic acid
JPS6044284B2 (ja) 医薬組成物
US3917839A (en) Treatment of ethanol withdrawal symptoms with methergoline
JP3027696B2 (ja) 安定な水性医薬組成物
JPH1045577A (ja) 風邪用咳止め薬

Legal Events

Date Code Title Description
BV The patent application has lapsed